Krystal Biotech Inc (KRYS)
177.41
-6.81
(-3.70%)
USD |
NASDAQ |
Nov 14, 16:00
177.41
0.00 (0.00%)
After-Hours: 20:00
Krystal Biotech Free Cash Flow: 58.06M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 58.06M |
| June 30, 2024 | -22.76M |
| March 31, 2024 | -54.44M |
| December 31, 2023 | -100.60M |
| September 30, 2023 | -119.07M |
| June 30, 2023 | -129.81M |
| March 31, 2023 | -152.40M |
| December 31, 2022 | -153.55M |
| September 30, 2022 | -187.78M |
| June 30, 2022 | -182.29M |
| March 31, 2022 | -136.83M |
| December 31, 2021 | -116.27M |
| September 30, 2021 | -69.72M |
| June 30, 2021 | -52.44M |
| Date | Value |
|---|---|
| March 31, 2021 | -45.32M |
| December 31, 2020 | -40.93M |
| September 30, 2020 | -34.97M |
| June 30, 2020 | -29.46M |
| March 31, 2020 | -27.90M |
| December 31, 2019 | -25.09M |
| September 30, 2019 | -20.63M |
| June 30, 2019 | -17.96M |
| March 31, 2019 | -14.23M |
| December 31, 2018 | -11.68M |
| September 30, 2018 | -9.143M |
| June 30, 2018 | -7.481M |
| March 31, 2018 | -6.205M |
| December 31, 2017 | -4.10M |
Free Cash Flow Range, Past 5 Years
-187.78M
Minimum
Sep 2022
58.06M
Maximum
Sep 2024
-81.18M
Average
-62.08M
Median
Free Cash Flow Benchmarks
| Bioventus Inc | 29.05M |
| ADMA Biologics Inc | 78.82M |
| Alnylam Pharmaceuticals Inc | 16.06M |
| Amicus Therapeutics Inc | -31.51M |
| Apellis Pharmaceuticals Inc | -205.58M |